Back to Search
MARC LORIAUX, MD
MD
Hematology (Pathology) Physician
NPI: 1215943824IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Pathology) PhysicianPrimary
Pathology — Hematology
Code: 207ZH0000X
MD22768(OR)
CMS Specialties
PrimaryPATHOLOGY
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
PMID 18252861·Blood·2008
8-other
Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.
PMID 15512807·Leuk Lymphoma·2004
6-review
Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.
PMID 19340004·Leukemia·2009
8-other
High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia.
PMID 18615102·Leukemia·2009
8-other
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.
PMID 19075190·Blood·2009
7-preclinical
RNAi screen for rapid therapeutic target identification in leukemia patients.
PMID 19433805·Proc Natl Acad Sci U S A·2009
8-other
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
PMID 18559973·Blood·2008
7-preclinical
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
PMID 18025156·Blood·2008
8-other
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles.
PMID 18068628·Cancer Cell·2007
7-preclinical
Activating alleles of JAK3 in acute megakaryoblastic leukemia.
PMID 16843266·Cancer Cell·2006
7-preclinical
Characterization of murine JAK2V617F-positive myeloproliferative disease.
PMID 17145859·Cancer Res·2006
7-preclinical
Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemia.
PMID 16543062·Exp Hematol·2006
7-preclinical
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.
PMID 16081687·Blood·2005
3-trial
Fallopian tube occlusion with use of a small intestine submucosa device: evaluation in a rabbit model.
PMID 15178722·J Vasc Interv Radiol·2004
7-preclinical
Ph-positive and -negative myeloproliferative syndromes may co-exist.
PMID 15103389·Leukemia·2004
8-other
c-CBL is not required for leukemia induction by Bcr-Abl in mice.
PMID 14654781·Oncogene·2003
7-preclinical
Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
PMID 12646934·Leukemia·2003
8-other
Lack of suitability of the rabbit model for particulate uterine artery embolization.
PMID 12050301·J Vasc Interv Radiol·2002
7-preclinical
Bifurcated drum occluder endograft for treatment of abdominal aortic aneurysm: an experimental study in dogs.
PMID 11287515·J Vasc Interv Radiol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-8276
Quick Facts
- NPI
- 1215943824
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile